Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


Depression also a problem in patients with Parkinson’s


While Parkinson’s disease typically brings to mind symptoms such as tremors and slow movement, researchers have found that nearly half of all Parkinson’s patients also suffer from depression. While it might seem natural that someone who has a disease such as Parkinson’s might become depressed, it’s not so simple, says neurologist Irene Richard, M.D., of the University of Rochester Medical Center.

"Many patients assume that’s it’s normal to feel this way. They might say, ’If you had Parkinson’s disease, you’d feel this way too.’ That’s not true. If you treat the depression, they’ll still have the other symptoms of the disease, but they feel better. It’s one aspect of the disease that may be very treatable," says Richard. "People diagnosed with other serious diseases that may also be disabling, such as rheumatoid arthritis, aren’t nearly as likely to become depressed."

Richard and co-author William McDonald, M.D., a psychiatrist at Emory University, discussed the links between depression and movement disorders like Parkinson’s disease in a review article in the August 24 issue of the journal Neurology. In an article titled, "Can ’blue’ genes affect mood and movement?" the two noted that a team from Columbia University has linked a gene known to cause a movement disorder known as dystonia with a type of early-onset depression. Now they and other physicians around the country are exploring possible links between mood and movement in other disorders such as Parkinson’s disease.

Of Parkinson’s patients who become depressed, about half have "major" depression that has a significant impact on their lives, while others have milder forms of depression that are still distressing. "There’s a huge amount of suffering out there due to the depression that comes so frequently as part of Parkinson’s disease," says Richard, who is an expert on the psychiatric aspects of the disease. Patients who have lost the pleasure they once took in activities or hobbies, or who are having difficulty sleeping or have a poor appetite, have common symptoms of depression.

"The depression is part of the illness, not simply a reaction to the disease. We’ve found that if a physician brings up the topic, patients will be honest and will discuss their depression, but oftentimes they won’t bring it up themselves. But depression is the number-one factor responsible for poor quality of life among these patients. We need to educate physicians to ask about this in their patients with Parkinson’s disease," says Richard, an associate professor of Neurology and Psychiatry.

Doctors estimate that about 1 million people in North America have Parkinson’s disease, which targets a small group of cells in a part of the brain known as the substantia nigra that produce a chemical called dopamine. The loss of these brain cells results in abnormal signals to other parts of the brain, which Richard says appears to influence a person’s mood. In addition, the disease also affects cells that produce brain chemicals such as serotonin and norepinephrine, which can play a role in depression.

Richard and McDonald are leading a national research study to test the effectiveness of anti-depressants in treating some of the symptoms of Parkinson’s disease. The study will evaluate common anti-depressant medications paroxetine (brand name Paxil) and venlafaxine (brand name Effexor) at treating the depression that patients experience. Richard says that until now, there hasn’t been a large placebo-controlled study to see how well anti-depressant medications actually work in patients with Parkinson’s. The disease wreaks havoc in the brain and may cause such medications to work differently than they do in healthy people.

The study will include 228 patients at 15 sites around the nation. The four-year, $4 million study is being funded by the National Institute of Neurological Disorders and Stroke.

Tom Rickey | EurekAlert!
Further information:

More articles from Health and Medicine:

nachricht Resolving the mystery of preeclampsia
21.10.2016 | Universitätsklinikum Magdeburg

nachricht New potential cancer treatment using microwaves to target deep tumors
12.10.2016 | University of Texas at Arlington

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: New 3-D wiring technique brings scalable quantum computers closer to reality

Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.

"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...

Im Focus: Scientists develop a semiconductor nanocomposite material that moves in response to light

In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.

A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...

Im Focus: Diamonds aren't forever: Sandia, Harvard team create first quantum computer bridge

By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.

"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...

Im Focus: New Products - Highlights of COMPAMED 2016

COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.

In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...

Im Focus: Ultra-thin ferroelectric material for next-generation electronics

'Ferroelectric' materials can switch between different states of electrical polarization in response to an external electric field. This flexibility means they show promise for many applications, for example in electronic devices and computer memory. Current ferroelectric materials are highly valued for their thermal and chemical stability and rapid electro-mechanical responses, but creating a material that is scalable down to the tiny sizes needed for technologies like silicon-based semiconductors (Si-based CMOS) has proven challenging.

Now, Hiroshi Funakubo and co-workers at the Tokyo Institute of Technology, in collaboration with researchers across Japan, have conducted experiments to...

All Focus news of the innovation-report >>>



Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

Agricultural Trade Developments and Potentials in Central Asia and the South Caucasus

14.10.2016 | Event News

World Health Summit – Day Three: A Call to Action

12.10.2016 | Event News

Latest News

Resolving the mystery of preeclampsia

21.10.2016 | Health and Medicine

Stanford researchers create new special-purpose computer that may someday save us billions

21.10.2016 | Information Technology

From ancient fossils to future cars

21.10.2016 | Materials Sciences

More VideoLinks >>>